Small peptides specifically bind to colorectal cancers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8435490
APP PUB NO 20100183511A1
SERIAL NO

12664302

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Cancers are extremely heterogeneous in terms of the frequency and types of mutations present in different malignant tumors. Thus, it is likely that uniform clinical treatment is not optimal for all patients, and that the development of individualized therapeutic regimens may be beneficial. Multiple, unique small peptides bind to cell lines derived from different colon adenocarcinomas. Within two hours of contact, the colorectal cancer cells are able to transfer a 32P radioisotope from the small peptides to cellular proteins; the transfer occurs at a substantially higher rate than in the colorectal cancer cells than in cell lines derived from other cancers or from normal tissues.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE JOHNS HOPKINS UNIVERSITY34TH AND CHARLES STREET BALTIMORE MD 21218

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abraham, John Martin Woodbine, US 4 0
Meltzer, Stephen J Lutherville, US 17 124

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation